{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:42:21Z","timestamp":1756572141354,"version":"3.41.2"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Periodic paralysis is a rare muscle disease that manifests as episodes of painless muscle weakness, and the hypokalemic form is commonly associated with hyperthyroidism. Most tachyarrhythmias related with thyrotoxicosis include sinus tachycardia and atrial fibrillation, but an association between thyrotoxic hypokalemic periodic paralysis and typical atrial flutter has seldomly been documented. Here, we present the case of a young male who was diagnosed with thyrotoxic periodic paralysis causing cavotricuspid isthmus-dependent atrial flutter, successfully treated with diltiazem, propranolol, methimazole, potassium iodine (SSK) and rivaroxaban.<\/jats:p>","DOI":"10.1093\/omcr\/omac020","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:35:29Z","timestamp":1647603329000},"source":"Crossref","is-referenced-by-count":2,"title":["When cardiology meets endocrinology: sustained atrial flutter associated with thyrotoxic periodic paralysis"],"prefix":"10.1093","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-5032","authenticated-orcid":false,"given":"Alejandro","family":"Sanchez-Nadales","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Disease, Cleveland Clinic Florida, Weston, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Celis-Barreto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mount Sinai Medical Center of Florida, Miami Beach, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Diaz-Sierra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Sanchez-Nadales","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universidad Central de Venezuela Facultad de Medicina, Caracas, Distrito Capital, Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Cleveland Clinic Florida, Weston, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-6289","authenticated-orcid":false,"given":"Jose","family":"Sleiman","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Cleveland Clinic Florida, Weston, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"2022031811301095700_ref1","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"2022031811301095700_ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1573397112666160404124822","article-title":"Thyrotoxic periodic paralysis: a concise review of the literature","volume":"12","author":"Ali Chaudhry","year":"2016","journal-title":"Curr Rheumatol Rev"},{"key":"2022031811301095700_ref3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jemermed.2003.05.004","article-title":"The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature","volume":"26","author":"Tassone","year":"2004","journal-title":"J Emerg Med"},{"key":"2022031811301095700_ref4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archneur.1983.04050080039005","article-title":"Intravenous treatment of hypokalemic periodic paralysis","volume":"40","author":"Griggs","year":"1983","journal-title":"Arch Neurol"},{"key":"2022031811301095700_ref5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9343(74)90010-2","article-title":"Thyrotoxic periodic paralysis: effect of propranolol","volume":"57","author":"Yeung","year":"1974","journal-title":"Am J Med"},{"key":"2022031811301095700_ref6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the North American Society of Pacing and Electrophysiology","volume":"38","author":"Fuster","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2022031811301095700_ref7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: a comprehensive guide for clinicians","volume":"20","author":"Hamilton","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"2022031811301095700_ref8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijcard.2016.11.053","article-title":"Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation","volume":"228","author":"Souza","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2022\/3\/omac020\/42908951\/omac020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2022\/3\/omac020\/42908951\/omac020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:35:38Z","timestamp":1647603338000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omac020\/6549473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omac020","relation":{},"ISSN":["2053-8855"],"issn-type":[{"type":"electronic","value":"2053-8855"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,3,1]]},"article-number":"omac020"}}